Aethlon Medical, Inc. (OTCBB: AEMD), a medical device company that addresses cancer, Hepatitis C, sepsis and other infectious diseases, recently released the following note authored by its Chairman and CEO, Jim Joyce. The release discusses new developments in the understanding of the role of exosomes in the spread of metastatic breast cancer. In light of these